| Lower prevalence of hypertension, hypercholesterolemia, and diabetes in marathoners. | |
| | |
MedLine Citation:
|
PMID: 19204599 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To test whether the prevalence of hypertension, hypercholesterolemia, and diabetes declines with marathon participation independent of annual running mileage. METHODS: Cross-sectional associations of self-reported medication use in 62,284 male and 45,040 female participants of the National Runners' Health Study adjusted for age, diet, alcohol, and annual distance run. RESULTS: By self-report, 31.7% of men and 29.1% of women ran 0.2 and 0.8 marathons per year, 8.6% of men and 4.4% of women ran between 1.0 and 1.8 marathons per year, and 3.8% of men and 1.5% of women ran an average of >or=2 marathons per year. The men's odds ratio per marathons per year run was 0.85 for antihypertensive (P < 0.0001), 0.87 for LDL-cholesterol-lowering (P = 0.002), and 0.52 for antidiabetic medication use (P < 0.0001). Compared with nonmarathoners, men who averaged 0.2-0.8 marathons per year had 13% lower odds for antihypertensive medication use, 22% lower odds for LDL-cholesterol-lowering medication use, and 67% lower odds for antidiabetic medication use. Marathon participation was also associated with lower LDL-cholesterol-lowering and antidiabetic medication use in women, but not when adjusted for annual distance run. Each additional hour required to complete their marathon had odds ratio of 1.31 and 1.22 for men's antihypertensive and LDL-cholesterol-lowering medication use and 2.01 for women's antidiabetic medication use (all P < 0.0001). Among all runners (marathoners and nonmarathoners combined), prevalence in the use of all three medications decreased in association with the length of the longest usual run, independent of total annual mileage. CONCLUSION: Prevalence of hypertension, hypercholesterolemia, and diabetes decreases with the frequency of marathon participation independent of annual running distance. This may be due to the inclusion of longer training runs in preparation for marathons or to genetic or other innate differences between marathon and nonmarathon runners. |
| | |
Authors:
|
Paul T Williams |
Related Documents
:
|
17661559 - The talmud and human lactation: the cultural basis for increased frequency and duration... 10846329 - The counseling component of medical abortion. 1624009 - Recurrence of myomas after myomectomy in women pretreated with leuprolide acetate depot... 15121559 - Ultrasound evaluation of the endometrium after medical termination of pregnancy. 18482139 - A review of developments in medical termination of pregnancy. 11943579 - Liminality and breastfeeding: women negotiating space and two bodies. 10168949 - Integrating medical informatics into the medical undergraduate curriculum. 19680219 - Carbon monoxide exposures after hurricane ike - texas, september 2008. 3423849 - Folk flu and viral syndrome: an epidemiological perspective. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. |
Journal Detail:
|
Title: Medicine and science in sports and exercise Volume: 41 ISSN: 1530-0315 ISO Abbreviation: Med Sci Sports Exerc Publication Date: 2009 Mar |
Date Detail:
|
Created Date: 2009-02-19 Completed Date: 2009-05-28 Revised Date: 2011-09-26 |
Medline Journal Info:
|
Nlm Unique ID: 8005433 Medline TA: Med Sci Sports Exerc Country: United States |
Other Details:
|
Languages: eng Pagination: 523-9 Citation Subset: IM; S |
Affiliation:
|
Life Sciences Division, Lawrence Berkeley Laboratory, Donner Laboratory, Berkeley, CA 94720, USA. ptwilliams@lbl.gov |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Anticholesteremic Agents / therapeutic use Antihypertensive Agents / therapeutic use Cross-Sectional Studies Diabetes Mellitus / epidemiology* Drug Utilization Female Humans Hypercholesterolemia / epidemiology* Hypertension / epidemiology* Hypoglycemic Agents / therapeutic use Male Middle Aged Running* / statistics & numerical data Sex Factors United States / epidemiology |
| Grant Support | |
ID/Acronym/Agency:
|
DK066738/DK/NIDDK NIH HHS; HL-45652/HL/NHLBI NIH HHS; HL-72110/HL/NHLBI NIH HHS; R01 DK066738-04/DK/NIDDK NIH HHS; R01 HL072110-04/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Anticholesteremic Agents; 0/Antihypertensive Agents; 0/Hypoglycemic Agents |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Test-retest reliability of the Women's Health Initiative physical activity questionnaire.
Next Document: Changes in weight and physical activity over two years in Spanish alumni.